For the first time, Morocco has exported cannabis legally produced on its soil. Sold for between 1,400 and 1,800 euros per kilo, a quintal (100 kg) of resin with a THC content of less than 1% was sent to Switzerland in the second quarter.
The pharmaceutical laboratory Sothema, which achieved a turnover of 230 million euros in 2023, indicates that it has developed around fifteen cannabis-based drugs with a high THC content. To “treat painful pathologies such as cancer, multiple sclerosis or epilepsy” , explains Khalid El Attaoui.
The director of the subsidiary Axess Pharma, specialized in anti-cancer treatments, plans to market them by 2025. In his sights, the Moroccan and European markets, mainly Germany Denmark, Switzerland, Italy and France, which recently authorized medical cannabis on an experimental basis.
France is not just an export target. French companies participate in interest groups in Morocco, including the Moroccan cooperative Bio CANNAT, which has processed some of the cannabis exported to Switzerland. Its director, Aziz Makhlouf, does not wish to disclose the identity of the companies that have grouped together, nor his income, which is “confidential” , but assures that 80% comes from the local market.
Get the details here.
